About acura pharmaceuticals inc - ACUR
Acura Pharmaceuticals, Inc. is a drug delivery company, which engages in the research, development, and commercialization of technologies and products intended to address safe use of medications. Its technology platforms include Aversion, Impede, and LIMITx. The company was founded on April 10, 1935 and is headquartered in Palatine, IL.
ACUR At a Glance
Acura Pharmaceuticals, Inc.
616 N. North Court
Palatine, Illinois 60067
| Phone | 1-847-705-7709 | Revenue | 1.56M | |
| Industry | Pharmaceuticals: Major | Net Income | -879,000.00 | |
| Sector | Health Technology | Employees | 9 | |
| Fiscal Year-end | 12 / 2022 | |||
| View SEC Filings |
ACUR Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 18.171 |
| Price to Book Ratio | 183.15 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -26.495 |
| Enterprise Value to Sales | 18.257 |
| Total Debt to Enterprise Value | 0.007 |
ACUR Efficiency
| Revenue/Employee | 173,666.667 |
| Income Per Employee | -97,666.667 |
| Receivables Turnover | 9.892 |
| Total Asset Turnover | 1.204 |
ACUR Liquidity
| Current Ratio | 0.722 |
| Quick Ratio | 0.722 |
| Cash Ratio | 0.126 |
ACUR Profitability
| Gross Margin | 94.242 |
| Operating Margin | -74.664 |
| Pretax Margin | -56.238 |
| Net Margin | -56.238 |
| Return on Assets | -67.72 |
| Return on Equity | N/A |
| Return on Total Capital | -232.54 |
| Return on Invested Capital | N/A |
ACUR Capital Structure
| Total Debt to Total Equity | 112.36 |
| Total Debt to Total Capital | 52.91 |
| Total Debt to Total Assets | 23.256 |
| Long-Term Debt to Equity | 93.82 |
| Long-Term Debt to Total Capital | 44.18 |